Abstract:Diffusion magnetic resonance imaging (dMRI) provides insight into white matter (WM) microstructural changes in Alzheimer’s disease and mild cognitive impairment (MCI). The Alzheimer’s Disease Neuroimaging Initiative’s (ADNI) has currently extended its ADNI3 imaging protocol to include dMRI from Siemens, Philips and General Electric (GE) scanners, resulting in seven vendor‐specific dMRI acquisition protocols (Table1). Here we present the updated ADNI3 preprocessing pipeline1 (Figure1) for diffusion tensor imaging (DTI) metrics made available via ADNI’s database, and evaluate their utility for detecting WM differences associated with clinical impairment. Raw dMRI downloaded from ADNI are first denoised using DiPy’s principal component analysis (PCA) denoising algorithms: local PCA for zero‐padded k‐space data (GE), or Marchenko‐Pastur PCA for data with the original acquisition matrix (Siemens/Philips). dMRI are then corrected for Gibbs ringing, eddy currents using FSL’s eddy_cuda with repol outlier estimation and slice‐to‐volume correction, intensity inhomogeneity with ANTS N4, and echo‐planar imaging distortions with a three‐channel non‐linear registration of the subject‐level preprocessed average B0 image to the subject’s skull‐stripped T1‐weighted MRI. Bias field correction is applied again to dMRI with FSL‐FAST. DTI fractional anisotropy (FA), axial, mean and radial diffusivity (AxD, MD, RD) are estimated with FSL’s dtifit, using weighted least squares. The JHU ICBM‐DTI‐81 atlas FA is warped to subject‐level FA maps using ANTS, and the transformations are applied to atlas labels. Subject‐level mean and robust mean (using M‐estimator from R’s ‘WRS2’ package) of DTI metrics within 73 WM regions of interest (ROIs; Table2) are extracted. Here, we fit linear mixed effects models of diagnosis (N=733) and clinical dementia rating (CDR‐sob; N=682; Table3) in 28 of the 73 available ROIs, covarying for age, sex, age*sex, and including nested protocol|site variables as random effects; multiple comparisons were corrected for using false discovery rate (q=0.05). Lower anisotropy and greater diffusivity were associated with greater impairment, particularly in the hippocampal cingulum (Figure2). Results from mean and robust mean metrics were comparable. Overall, our results follow previous work2,3 using publicly available ADNI dMRI. Subject‐level ADNI3 dMRI measures, sensitive to clinical indices of impairment as presented here, are available at https://ida.loni.usc.edu/. References: [1 ]Thomopoulos (2021), https://doi.org/10.1117/12.2606337; [2] Nir (2013), https://doi.org/10.1016/j.nicl.2013.07.006; [3] Zavaliangos‐Petropulu (2019), https://doi.org/10.3389/fninf.2019.00002.

Toward diffusion tensor imaging as a biomarker in neurodegenerative diseases: technical considerations to optimize recordings and data processing

Current Clinical Applications of Diffusion-Tensor Imaging in Neurological Disorders

Magnetic Resonance Imaging Studies of Neurodegenerative Disease: from Methods to Translational Research

An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease

Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease

The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease

Advances in neuroimaging to support translational medicine in dementia

Diffusion Tensor Imaging (DTI)-based White Matter Mapping in Brain Research: A Review

NODDI in clinical research

MR Diffusion Tensor Imaging (DTI) and Neuropsychological Testing for Neuronal Connectivity in Alzheimer's Disease (AD) Patients

Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease

Diffusion Tensor Imaging in Hemorrhagic Stroke.

Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke

Effects of Dementia and MCI on Diffusion Tensor Metrics Using the Updated ADNI3 DTI Preprocessing Pipeline

Towards a quantitative assessment of neurodegeneration in Alzheimer's disease

Assessing Microstructural Substrates of White Matter Abnormalities: A Comparative Study Using DTI and NODDI

NODDI-DTI: Estimating Neurite Orientation and Dispersion Parameters from a Diffusion Tensor in Healthy White Matter

Methodological improvements in voxel-based analysis of diffusion tensor images: applications to study the impact of apolipoprotein E on white matter integrity

Optimization of image preprocessing for diffusion tensor magnetic resonance imaging

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease

Characterizing patterns of diffusion tensor imaging variance in aging brains